Overexpression of IL-15 in vivo enhances Tc1 response, which inhibits allergic inflammation in a murine model of asthma

被引:46
作者
Ishimitsu, R
Nishimura, H
Yajima, T
Watase, T
Kawauchi, H
Yoshikai, Y [1 ]
机构
[1] Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Lab Host Def & Germfree Life, Nagoya, Aichi 4668550, Japan
[2] Shimane Med Univ, Dept Otorhinolaryngol, Izumo, Shimane 693, Japan
关键词
D O I
10.4049/jimmunol.166.3.1991
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-15, a pleiotropic cytokine, is involved in the inflammatory responses in various infectious and autoimmune diseases. We have recently constructed IL-15-transgenic (Tg) mice, which have an increased number of memory-type CD8(+) T cells in the peripheral lymphoid tissues. In the present study, we found that eosinophilia and Th2-type cytokine production in the airway were severely attenuated in OVA-sensitized IL-15-Tg mice following OVA inhalation, IL-15-Tg mice preferentially developed Tc1 responses mediated by CD8(+) T cells after OVA sensitization, and in vivo depletion of CD8+ T cells by anti-CDS mAb aggravated the allergic airway inflammation in IL-15-Tg mice following OVA inhalation. Adoptive transfer of CD8(+) T cells from OVA-sensitized IL-15-Tg mice into normal mice before OVA sensitization suppressed Th2 response to OVA in the normal mice. These results suggest that overexpression of IL-15 in vivo suppresses Th2-mediated-allergic airway response via induction of CD8(+) T cell-mediated Tc1 response.
引用
收藏
页码:1991 / 2001
页数:11
相关论文
共 58 条
  • [1] Decreased prevalence of atopy in rheumatoid arthritis
    Allanore, Y
    Hilliquin, P
    Coste, J
    Renoux, M
    Menkès, CJ
    [J]. LANCET, 1998, 351 (9101) : 497 - 497
  • [2] Early BCG vaccination and development of atopy
    Alm, JS
    Lilja, G
    Pershagen, G
    Scheynius, A
    [J]. LANCET, 1997, 350 (9075) : 400 - 403
  • [3] CHROMOSOMAL ASSIGNMENT AND GENOMIC STRUCTURE OF IL15
    ANDERSON, DM
    JOHNSON, L
    GLACCUM, MB
    COPELAND, NG
    GILBERT, DJ
    JENKINS, NA
    VALENTINE, V
    KIRSTEIN, MN
    SHAPIRO, DN
    MORRIS, SW
    GRABSTEIN, K
    COSMAN, D
    [J]. GENOMICS, 1995, 25 (03) : 701 - 706
  • [4] ARMITAGE RJ, 1995, J IMMUNOL, V154, P483
  • [5] Avice MN, 1998, J IMMUNOL, V161, P3408
  • [6] THE INTERLEUKIN (IL)-2 RECEPTOR-BETA CHAIN IS SHARED BY IL-2 AND A CYTOKINE, PROVISIONALLY DESIGNATED IL-T, THAT STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS
    BAMFORD, RN
    GRANT, AJ
    BURTON, JD
    PETERS, C
    KURYS, G
    GOLDMAN, CK
    BRENNAN, J
    ROESSLER, E
    WALDMANN, TA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4940 - 4944
  • [7] Barnes PJ, 1998, PHARMACOL REV, V50, P515
  • [8] The kinetics of change in cytokine production by CD4+T cells during conventional allergen immunotherapy
    Benjaponpitak, S
    Oro, A
    Maguire, P
    Marinkovich, V
    DeKruyff, RH
    Umetsu, DT
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (03) : 468 - 475
  • [9] THE EFFECTS OF NEBULIZED RECOMBINANT INTERFERON-GAMMA IN ASTHMATIC AIRWAYS
    BOGUNIEWICZ, M
    MARTIN, RJ
    MARTIN, D
    GIBSON, U
    CELNIKER, A
    WILLIAMS, M
    LEUNG, DYM
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 133 - 135
  • [10] Borger P, 1999, IMMUNOLOGY, V96, P207